Form 4: Amgen Executive Jonathan P. Graham Reports Gift of Shares to Irrevocable Trusts

Amgen's Executive Vice President and General Counsel, Jonathan P. Graham, reported gifting 6,430 shares of common stock to irrevocable trusts for his adult children.

Summary

• Jonathan P. Graham, an Executive Vice President and General Counsel at Amgen, filed a Form 4 disclosing a transaction on December 5, 2024.
• Mr. Graham gifted 6,430 shares of Amgen common stock to two irrevocable trusts for the benefit of his adult children.
• The shares were gifted at a price of $0, indicating a non-sale transfer.
• Following the transaction, Mr. Graham directly owns 28,903 shares of Amgen stock, which includes 550 Dividend Equivalents (DEs).
• These DEs are granted under Amgen's 2009 Equity Incentive Plan and are paid out in shares upon vesting of associated Restricted Stock Units (RSUs).

Sentiment

Score: 7

Explanation: The document is a routine filing and does not indicate any positive or negative sentiment. It is a neutral transaction related to executive stock ownership.

Industry Context

This is a routine filing related to executive stock ownership and does not indicate any significant industry trends or competitive shifts.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders to report changes in their beneficial ownership of company stock.
• The gifting of shares to family trusts is a common estate planning strategy among executives.
• The use of Dividend Equivalents (DEs) as part of equity compensation is also a common practice in the industry.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a transfer of shares from an executive to family trusts and does not affect the total number of outstanding shares.

Key Dates

Keywords

Amgen, Form 4, insider trading, share transfer, Jonathan P. Graham, irrevocable trusts, executive compensation, dividend equivalents, equity incentive plan